Comparison of poor responders with good responders using intentionally frozen-thawed epididymal spermatozoa in subsequent ICSI cycles

Clinical and Experimental Obstetrics and Gynecology

Volumn 29, Issue 2, 2002, Pages 131-134

  Nikolettos, N ^a   Al Hasani, S ^a   Kupker W ^a   Vakalopoulos, I ^a   Asimakopoulos, B ^a   Fornara, P ^a   Diedrich, K ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Epididymal spermatozoa; ICSI; Male factor infertility; Ovarian response

Indexed keywords

ESTRADIOL; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; AZOOSPERMIA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYOPRESERVATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HORMONAL REGULATION; HUMAN; HUMAN CELL; INTRACYTOPLASMIC SPERM INJECTION; METAPHASE; OUTCOMES RESEARCH; OVARY HYPERSTIMULATION; PREGNANCY RATE; SPERMATOZOON; TECHNIQUE; THAWING; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME; SPERM PRESERVATION; TRANSPLANTATION;

ADULT; COMPARATIVE STUDY; CRYOPRESERVATION; FEMALE; HUMAN; MALE; MIDDLE AGE; PREGNANCY; PREGNANCY OUTCOME; SEMEN PRESERVATION; SPERM INJECTIONS, INTRACYTOPLASMIC; TISSUE HARVESTING; HUMANS; MIDDLE AGED; TISSUE AND ORGAN HARVESTING;

EID: 0035990750     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Mini swim-up: A new technique of sperm preparation for ICSI
2. Managing nonresponders
3. Limitations in the use of combined gonadotropin releasing hormone analog and human menopausal gonadotropin for in vitro fertilisation
4. Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone-agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels
5. Ongoing pregnancies and birth after intracytoplasmic sperm injection with frozen-thawed epididymal spermatozoa
6. Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels
7. A prospective randomised comparison between long and discontinuous-long protocols of gonadotropin releasing hormone agonist for in vitro fertilization
8. Comparison of 'poor' responders with 'good' responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization
9. The importance of the follicular phase to success and failure in in vitro fertilisation
10. High-dose human menopausal gonadotrophin stimulation in poor responders does not improve the in vitro fertilization outcome
11. Poor responders to ovulation induction: Is proceeding to in-vitro fertilization worthwhile?
12. Routine pituitary suppression with leuprolide before ovarian stimulation, for oocyte retrieval
13. Using ejaculated, fresh and frozen-thawed epididymal and testicular spermatozoa gives rise to comparable results after intracytoplasmic sperm injection
14. Efficacy of intracytoplasmic sperm injection using intentionally cryopreserved epididymal spermatozoa
15. Hypersecretion of luteinising hormone, infertility, and miscarriage
16. An alternate approach to controlled ovarian hyperstimulation in 'poor responders': Pre-treatment with a gonadotropin-releasing hormone analog
17. Conventional in-vitro fertilization versus intracytoplasmic sperm injection for patients requiring microsurgical sperm aspiration
18. The use of epididymal and testicular spermatozoa for intracytoplasmic sperm injection: The genetic implications for male infertility
19. Microsurgical epididymal sperm aspiration and intracytoplasmic sperm injection: A new effective approach to infertility as a result of congenital absence of the vas deferens
20. Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: A randomised study
21. High fertilization and implantation rates after ICSI